OpenEvidence
OpenEvidence · Point of care · Web/mobile app
Clinical Evidence & Decision Support
AI-powered clinical evidence synthesis for physicians, grounded in the medical literature (NEJM/JAMA corpus partnerships), free to verified US clinicians; fastest clinician adoption curve of any CDS startup on record.
Evidence at a glance
Freshness, source-checked counts, confidence and gate results below reflect the frozen evidence snapshot through . A later editorial review does not update these results.
- Stated intended users
- Practicing clinicians (all specialties)
- Documentary gate at snapshot
- Failed
- Scenario match
- No evaluated buying scenario currently covers this product
- Comparability
- Not yet comparable in this scenario
- Decision readiness at snapshot
- HISTORICAL — Research only
- Documented evidence at snapshot
- 0 of 2 evidence claims source-checked · confidence Moderate
- Critical unknowns
- scaled production deployment
- Latest checked-source retrieval in snapshot
- not yet measured
Expand each claim to inspect its source, dates and recorded verification status.
independent reportOpenEvidence, a tool that doctors and nurses have likened to ChatGPT for medicine, planned to announce a $200 million raise at a $6 billion …2025-10-20
Exact claim. OpenEvidence, a tool that doctors and nurses have likened to ChatGPT for medicine, planned to announce a $200 million raise at a $6 billion valuation; the round was led by Google Ventures, with participation from Sequoia Capital, Kleiner Perkins, Blackstone, Thrive Capital, Coatue Management, Bond, and Craft, and its number of clinical consultations per month has nearly doubled to 15 million since July.
- Source
- techcrunch.com
- Type
- independent report
- Published
- 2025-10-20
- Retrieved
- 2026-08-27
- Verification
- unverified
- Confidence
- not stated
- Reviewer
- healthit-gate-v1
- Claim version
- v1
- Supports
- economic_value
- Score contribution
- Feeds economic value
Independent source. Methodology and sample vary by report; read the underlying method.
Open techcrunch.compeer reviewed studyMayo Clinic study in J Prim Care Community Health (2025 Apr 16;16:21501319251332215, doi 10.1177/21501319251332215) found OpenEvidence 'prov…2025-04-16
Exact claim. Mayo Clinic study in J Prim Care Community Health (2025 Apr 16;16:21501319251332215, doi 10.1177/21501319251332215) found OpenEvidence 'provided accurate, evidence-based recommendations in all cases, aligning with physician plans' across five common chronic conditions, with mean scores of clarity 3.55±0.60, relevance 3.75±0.44, support 3.35±0.49, and satisfaction 3.60±0.60.
- Source
- pmc.ncbi.nlm.nih.gov
- Type
- peer reviewed study
- Published
- 2025-04-16
- Retrieved
- 2026-08-27
- Verification
- unverified
- Confidence
- not stated
- Reviewer
- healthit-gate-v1
- Claim version
- v1
- Supports
- evidence_strength
- Score contribution
- Feeds evidence strength
Peer-reviewed. Check population, setting, and applicability to your workflow before generalizing.
Open pmc.ncbi.nlm.nih.govVerified provider experience is not yet publishable. Fewer than five independent provider organizations have contributed eligible reviews. Reviewer mode is off. Experience never changes documentary scoring, freshness, or rank.
Buyer lenses — evidence-backed bands at snapshot (not a 0–100 rank)
Deployment, integration, data handling at snapshot
- Integration maturity
- announced — Announced or documented integration; marketplace listing not confirmed.
- EHR path
- None (standalone reference)
- FHIR / API
- UNKNOWN
Why unknown
Why. No reliable source on file. The platform does not infer values from weak sources.
What would close it. A primary source or independent verification.
- SSO
- UNKNOWN
Why unknown
Why. Single-sign-on support is not documented in vendor or marketplace materials on file.
What would close it. Vendor security documentation or marketplace listing mentioning SSO/SAML/OIDC.
- PHI / BAA
- No PHI by design (clinician queries only)
- Security attestations
- HIPAA-aligned (no-PHI posture)
- FDA status
- UNKNOWN
Why unknown
Why. No FDA listing found for this product's functions in the tracked category.
What would close it. An FDA 510(k)/De Novo listing, or a clear statement that no regulated function is claimed.
- Pricing
- NPI-verified free access as of 2026
Technical provenance
snap_36bba25c577cbb44 · Evidence cutoff: 2026-08-27T04:05Z · Snapshot generated: 2026-10-21T19:39Z · build ffbf5c3
Forecast calibration is not in the public snapshot — shown as UNKNOWN rather than read from SQLite.
Known limitations
- Deployment traction is UNKNOWN.
Why unknown
Why. No reliable source on file. The platform does not infer values from weak sources.
What would close it. A primary source or independent verification.